Please login to read the full article.
Scrip Regulatory Affairs
GAO says US FDA must do more to ensure accuracy of antibiotic labels
02 February 2012
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US lawmakers ask regulators to address underreporting of clinical trial data
- US FDA analysis blames poor quality 510(k) submissions for delays in reviews
- Trials on trial: 'short-term pain' needed for broken clinical enterprise
- Australia revises medical device reform proposals; third-party assessments put on hold
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
